Evidence map›Paper›PMID 34012031›Full record

ArticleNature communications2021

FKRP-dependent glycosylation of fibronectin regulates muscle pathology in muscular dystrophy.

A J Wood, C H Lin, M Li, K Nishtala, S Alaei, F Rossello, C Sonntag, L Hersey, L B Miles, C Krisp and 9 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 2 countries.

A J WoodAustralian Regenerative Medicine Institute (ARMI), Faculty of Medicine, Nursing and Health Science, Monash University, Clayton, VIC, Australia.
C H LinBiomolecular Discovery and Design Research Centre, Department of Molecular Sciences, Faculty of Science & Engineering, Macquarie University, Sydney, NSW, Australia.ORCID 0000-0003-1911-0034
M LiAustralian Regenerative Medicine Institute (ARMI), Faculty of Medicine, Nursing and Health Science, Monash University, Clayton, VIC, Australia.
K NishtalaBiomolecular Discovery and Design Research Centre, Department of Molecular Sciences, Faculty of Science & Engineering, Macquarie University, Sydney, NSW, Australia.ORCID 0000-0001-8410-9553
S AlaeiAustralian Regenerative Medicine Institute (ARMI), Faculty of Medicine, Nursing and Health Science, Monash University, Clayton, VIC, Australia.
F RosselloAustralian Regenerative Medicine Institute (ARMI), Faculty of Medicine, Nursing and Health Science, Monash University, Clayton, VIC, Australia.
C SonntagAustralian Regenerative Medicine Institute (ARMI), Faculty of Medicine, Nursing and Health Science, Monash University, Clayton, VIC, Australia.
L HerseyAustralian Regenerative Medicine Institute (ARMI), Faculty of Medicine, Nursing and Health Science, Monash University, Clayton, VIC, Australia.
L B MilesAustralian Regenerative Medicine Institute (ARMI), Faculty of Medicine, Nursing and Health Science, Monash University, Clayton, VIC, Australia.ORCID 0000-0002-2718-1353
C KrispBiomolecular Discovery and Design Research Centre, Department of Molecular Sciences, Faculty of Science & Engineering, Macquarie University, Sydney, NSW, Australia.
S DudczigAustralian Regenerative Medicine Institute (ARMI), Faculty of Medicine, Nursing and Health Science, Monash University, Clayton, VIC, Australia.
A J FulcherMonash Micro Imaging Facility, Monash University, Clayton, VIC, Australia.ORCID 0000-0002-6278-7211
S GibertiniMuscle Cell Biology Laboratory, Neuromuscular Diseases and Neuroimmunology Unit, Fondazione IRCCS Istituto Neurologico "Carlo. Besta" Via Temolo 4, Milano, Italy.
P J ConroyDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, Nursing and Health Science, Monash University, Melbourne, VIC, Australia.ORCID 0000-0002-9748-4704
A SiegelAustralian Regenerative Medicine Institute (ARMI), Faculty of Medicine, Nursing and Health Science, Monash University, Clayton, VIC, Australia.
M MoraMuscle Cell Biology Laboratory, Neuromuscular Diseases and Neuroimmunology Unit, Fondazione IRCCS Istituto Neurologico "Carlo. Besta" Via Temolo 4, Milano, Italy.ORCID 0000-0002-5765-2320
P JusufAustralian Regenerative Medicine Institute (ARMI), Faculty of Medicine, Nursing and Health Science, Monash University, Clayton, VIC, Australia.
N H PackerBiomolecular Discovery and Design Research Centre, Department of Molecular Sciences, Faculty of Science & Engineering, Macquarie University, Sydney, NSW, Australia.ORCID 0000-0002-7532-4021
P D CurrieAustralian Regenerative Medicine Institute (ARMI), Faculty of Medicine, Nursing and Health Science, Monash University, Clayton, VIC, Australia. peter.currie@monash.edu.ORCID 0000-0001-8874-8862
Australian Regenerative Medicine Institute · AUGriffith University · AUThe University of Melbourne · AUFondazione IRCCS Istituto Neurologico Carlo Besta · ITMonash University · AUMacquarie University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The muscular dystrophies encompass a broad range of pathologies with varied clinical outcomes. In the case of patients carrying defects in fukutin-related protein (FKRP), these diverse pathologies arise from mutations within the same gene. This is surprising as FKRP is a glycosyltransferase, whose only identified function is to transfer ribitol-5-phosphate to α-dystroglycan (α-DG). Although this modification is critical for extracellular matrix attachment, α-DG's glycosylation status relates poorly to disease severity, suggesting the existence of unidentified FKRP targets. Here we reveal that FKRP directs sialylation of fibronectin, a process essential for collagen recruitment to the muscle basement membrane. Thus, our results reveal that FKRP simultaneously regulates the two major muscle-ECM linkages essential for fibre survival, and establishes a new disease axis for the muscular dystrophies.

Indexed as

AnimalsBasement MembraneCell LineDisease Models, AnimalFibronectinsGene Knockout TechniquesGlycosylationGlycosyltransferasesHumansMaleMuscle, SkeletalMuscular DystrophiesMuscular Dystrophies, Limb-GirdleMuscular Dystrophy, AnimalMutationMyoblasts, SkeletalFibronectinsFKRP protein, humanFKRP protein, zebrafishGlycosyltransferasesPentosyltransferasesZebrafish Proteins

Identifiers

PMID34012031
PMCPMC8134429
OpenAlexW3162531649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.